Lorazepam and Effient drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Effient (prasugrel hydrochloride). Common drug interactions include weight decreased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Effient. It is created by eHealthMe based on reports of 84 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Effient?

Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.



On Jul, 12, 2026

84 people who take Lorazepam and Effient together, and have interactions are studied.

Lorazepam and Effient drug interactions.

What are the common drug interactions of Lorazepam and Effient, by gender? *:

female:

  1. Weight decreased
  2. Abdominal distension
  3. Abnormal loss of weight
  4. Acute myocardial infarction (acute heart attack)
  5. Asthma
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Depression
  8. Disturbance in social behaviour
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypochromic anaemia (hypochromic anaemia is a generic term for any type of anaemia in which the red blood cells (erythrocytes) are paler than normal)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  4. Dehydration (dryness resulting from the removal of water)
  5. Headache (pain in head)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Vomiting
  8. Blood calcium decreased
  9. Blood cholesterol increased
  10. Blood phosphorus increased

What are the common drug interactions of Lorazepam and Effient, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Alopecia (absence of hair from areas of the body)
  2. Psychological trauma

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Ankle fracture
  6. Arthralgia (joint pain)
  7. Bone pain
  8. Cardiac disorder
  9. Crepitations (noises are produced by the rubbing of parts one against the other)
  10. Emotional distress

50-59:

  1. Blood phosphorus increased
  2. Chest discomfort
  3. Chest pain
  4. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  5. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  6. Dehydration (dryness resulting from the removal of water)
  7. Diarrhoea
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Flatulence (flatus expelled through the anus)
  10. Haemoglobin decreased

60+:

  1. Fatigue (feeling of tiredness)
  2. Acute myocardial infarction (acute heart attack)
  3. Erythema (redness of the skin)
  4. Hypersensitivity
  5. Nausea (feeling of having an urge to vomit)
  6. Neuralgia (pain in one or more nerves)
  7. Pneumonia
  8. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  9. Pain
  10. Abdominal pain

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 23 people, 27.38%
  2. High Blood Pressure: 20 people, 23.81%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 21.43%
  4. Pain: 10 people, 11.90%
  5. Chest Pain: 9 people, 10.71%
  6. Cardiac Disorder: 9 people, 10.71%
  7. Depression: 8 people, 9.52%
  8. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 5.95%
  9. Renal Disorder (kidney disease): 5 people, 5.95%
  10. Infection: 5 people, 5.95%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Effient?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lorazepam and Effient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Effient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effient and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and prasugrel hydrochloride (the active ingredients of Lorazepam and Effient, respectively), and Lorazepam and Effient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: